The Evidence to Support Medicalised Gender Transitions in Adolescents is Worryingly Weak

The Economist sets the record straight. The effectiveness and side-effects of the most common treatments are not well understood. Prisha Mosely was 17 when she was first given testosterone in a clinic in North Carolina, after she had declared to her parents that she was a boy. She had struggled through her teen years with … Continue reading The Evidence to Support Medicalised Gender Transitions in Adolescents is Worryingly Weak